Recombinant Human CRB1 Protein，GST

CRB1 (crumbs homologue 1) is a gene implicated in hereditary retinal diseases, especially in forms of retinitis pigmentosa and Leber congenital amaurosis. The CRB1 protein plays a critical role in maintaining the structure and function of photoreceptor cells in the retina. Research has shown that mutations in the CRB1 gene can lead to severe visual impairments due to the degeneration of these photoreceptors. To better understand the molecular mechanisms underlying these diseases, scientists have focused on the characterization of recombinant CRB1 protein. This involves expressing and purifying CRB1 in laboratory settings to study its biochemical properties, interactions with other proteins, and its functional role in retinal physiology. Additionally, recombinant CRB1 protein serves as a valuable tool for developing potential therapeutic strategies, such as gene therapy or protein replacement therapies aimed at restoring normal function in retinal cells affected by CRB1 mutations. Furthermore, studying the recombinant form of this protein provides insights into its involvement in cell signaling pathways and cellular architecture within the retina, ultimately aiding in the design of targeted interventions for CRB1-related retinal disorders. The ongoing research in this area is crucial for advancing our understanding of retinal degeneration and for the development of innovative treatments to mitigate the impact of CRB1 mutations on visual health.